NZ192927A - Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions - Google Patents

Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions

Info

Publication number
NZ192927A
NZ192927A NZ192927A NZ19292780A NZ192927A NZ 192927 A NZ192927 A NZ 192927A NZ 192927 A NZ192927 A NZ 192927A NZ 19292780 A NZ19292780 A NZ 19292780A NZ 192927 A NZ192927 A NZ 192927A
Authority
NZ
New Zealand
Prior art keywords
isopropylamino
pyrimidine
pharmaceutical compositions
hydroxy derivatives
hydroxy
Prior art date
Application number
NZ192927A
Other languages
English (en)
Inventor
A Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ192927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of NZ192927A publication Critical patent/NZ192927A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ192927A 1979-03-10 1980-02-20 Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions NZ192927A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
NZ192927A true NZ192927A (en) 1981-07-13

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ192927A NZ192927A (en) 1979-03-10 1980-02-20 Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions

Country Status (24)

Country Link
JP (1) JPS55122768A (US06623731-20030923-C00052.png)
AR (1) AR222691A1 (US06623731-20030923-C00052.png)
AU (1) AU533547B2 (US06623731-20030923-C00052.png)
BE (1) BE881752A (US06623731-20030923-C00052.png)
CA (1) CA1132561A (US06623731-20030923-C00052.png)
CH (1) CH644368A5 (US06623731-20030923-C00052.png)
DE (3) DE3050999C2 (US06623731-20030923-C00052.png)
EG (1) EG14282A (US06623731-20030923-C00052.png)
FI (1) FI66357C (US06623731-20030923-C00052.png)
FR (2) FR2451370A1 (US06623731-20030923-C00052.png)
GB (1) GB2045756B (US06623731-20030923-C00052.png)
HK (1) HK55383A (US06623731-20030923-C00052.png)
IE (1) IE49547B1 (US06623731-20030923-C00052.png)
IN (1) IN153791B (US06623731-20030923-C00052.png)
LU (1) LU82185A1 (US06623731-20030923-C00052.png)
MX (1) MX6218E (US06623731-20030923-C00052.png)
MY (1) MY8400200A (US06623731-20030923-C00052.png)
NL (1) NL184833C (US06623731-20030923-C00052.png)
NO (1) NO154054C (US06623731-20030923-C00052.png)
NZ (1) NZ192927A (US06623731-20030923-C00052.png)
OA (1) OA06484A (US06623731-20030923-C00052.png)
PT (1) PT70882A (US06623731-20030923-C00052.png)
SE (1) SE435180B (US06623731-20030923-C00052.png)
SG (1) SG22683G (US06623731-20030923-C00052.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (fr) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic Nouveau derive de l'isopropylamino pyrimidine, sa preparation et composition therapeutiques a base de ses composes
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
FR2451370B1 (US06623731-20030923-C00052.png) 1983-05-13
NL8001289A (nl) 1980-09-12
FI66357C (fi) 1984-10-10
AU533547B2 (en) 1983-12-01
MX6218E (es) 1984-12-21
NO800664L (no) 1980-09-11
DE3016752C2 (US06623731-20030923-C00052.png) 1987-06-25
EG14282A (en) 1983-09-30
NO154054B (no) 1986-04-01
IE49547B1 (en) 1985-10-30
CH644368A5 (en) 1984-07-31
AU5624880A (en) 1980-09-18
DE3009071C2 (de) 1985-11-14
NL184833B (nl) 1989-06-16
CA1132561A (en) 1982-09-28
GB2045756A (en) 1980-11-05
NL184468B (nl) 1989-03-01
NL184833C (nl) 1989-11-16
HK55383A (en) 1983-11-25
NO154054C (no) 1986-07-09
LU82185A1 (fr) 1980-06-06
AR222691A1 (es) 1981-06-15
OA06484A (fr) 1981-07-31
JPS55122768A (en) 1980-09-20
GB2045756B (en) 1983-01-26
DE3016752A1 (de) 1980-12-04
IN153791B (US06623731-20030923-C00052.png) 1984-08-18
FR2451191A1 (fr) 1980-10-10
FI66357B (fi) 1984-06-29
DE3050999A1 (US06623731-20030923-C00052.png) 1985-08-14
SE8001812L (sv) 1980-09-11
MY8400200A (en) 1984-12-31
FR2451191B1 (US06623731-20030923-C00052.png) 1983-04-29
BE881752A (fr) 1980-05-30
IE800477L (en) 1980-09-10
SE435180B (sv) 1984-09-10
FR2451370A1 (fr) 1980-10-10
JPS6126996B2 (US06623731-20030923-C00052.png) 1986-06-23
FI800566A (fi) 1980-09-11
SG22683G (en) 1983-12-16
PT70882A (en) 1980-03-01
DE3050999C2 (de) 1986-08-14
DE3009071A1 (de) 1980-09-11

Similar Documents

Publication Publication Date Title
IL60555A0 (en) Pharmaceutical compositions containing certain ureal derivatives
GB8315756D0 (en) Preparation of activated pharmaceutical compositions
NZ188320A (en) Thienothiazine derivatives preparation and pharmaceutical compositions
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
MY8700186A (en) 3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
DE3072103D1 (en) Pharmaceutical compositions containing 3-amino-pyrazoline derivatives
NZ192927A (en) Hydroxy derivatives of 2-isopropylamino-pyrimidine pharmaceutical compositions
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
NZ194784A (en) 7 -aminothiadizolylacetylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
NZ193344A (en) Pyran-4-one derivatives and pharmaceutical compositions
NZ193557A (en) 4-phenylchroman derivatives intermediates and pharmaceutical compositions
NZ194490A (en) 25-halocholest-5-ene-3 22-diol derivatives pharmaceutical compositions
PT72066A (en) Process for the preparation of novel halophenyl-pyridil-allylamine derivatives and pharmaceutical compositions thereof
IL58621A0 (en) Pharmaceutical compositions comprising aryltrifluoroethanol derivatives
PH16220A (en) Pyrro-lidine derivatives and pharmaceutical compositions thereof
NZ193421A (en) Preparation of isopropylaminopyrimidine hydroxy derivatives pharmaceutical compositions
NZ187285A (en) Azacyclic derivatives of 6-amino-penam compounds and pharmaceutical compositions
IL60695A (en) Hexahydro-trans-pyridoindole-alkanamine derivatives and pharmaceutical compositions containing them
IL61038A (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
NZ188040A (en) 1-phenylethanolamine derivatives pharmaceutical compositions
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
PH15436A (en) 4-amino-2-piperidinoquinazoline derivatives and pharmaceutical compositions thereof
IL60332A0 (en) Pyridylaminotriazole derivatives and pharmaceutical compositions containing them